Clin Osteol 2014; 19(2-3): 36-41

Bone mineral density in patients with cirrhosis of the liverOriginal contributions

Z. Kmečová, J. Vnenčáková, J. Šváč

Background: Decreased bone mineral density (BMD) is a common complication of liver cirrhosis.

Objective: This retrospective study of a group of patients with liver cirrhosis aime kers and assessing the relationship between decreased BMD and the studied variables.

Patients and methods: The group comprised 135 patients (88 males and 47 females) with liver cirrhosis. Patients' records were ma­ nually processed to obtain the studied variables (gender, age, body mass index [BMI], stage of disease, etiology of disease) and inves­ tigate their relationship with BMD. The DXA scan was used to measure BMD. The relationships between individual variables were assessed by p < 0.05.

Results: Decreased BMD was found in 63.69 % of patients with liver cirrhosis (44.44 % osteopenia, 19.25 % osteoporosis). There were no significant differences with respect to age, severity of disease or gender. There was an association between decreased BMD and BMI. The levels of statistical significance were achieved when the etiology of liver cirrhosis was compared. The most significant de­ crease in BMD was noted in patients with liver cirrhosis resulting from primary biliary cirrhosis and primary sclerosing cholangitis (76.46 %); the lowest decrease was associated with liver cirrhosis due to nonalcoholic steatohepatitis (38.45 %).

Conclusion: The study found that decreased BMD in liver cirrhosis is influenced by the etiology of cirrhosis, with BMI being a clear­ ly negative predictor of decreased BMD. Age has no effect on BMD values in patients with liver cirrhosis. Early diagnosis of decrea­ sed BMD allows timely preventive and therapeutic measures inhibiting the development of severe bone changes often leading to osteoporotic fractures, preventing patients from bein of patients with liver cirrhosis.

Keywords: liver cirrhosis, osteoporosis, densitometry Osteologický bulletin 2014;19(2-3)36-41

Published: December 11, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kmečová Z, Vnenčáková J, Šváč J. Bone mineral density in patients with cirrhosis of the liver. Osteologický bulletin. 2014;19(2-3):36-41.
Download citation

References

  1. Kiňová S, Hulín I a kol. Choroby tráviaceho systému. 1. vyd. Bratislava, ProLit 2011; s. 162.
  2. Ninkovic M, Love SA, Tom B et al. High Prevalence of Osteoporosis in Patients with Chronic Liver Disease prior to Liver Transplantation. Calcif Tissue Int 2001; 69:321-326. Go to original source...
  3. Payer J, Borovský M a kol. Osteoporóza pri vybraných ochoreniach. Bratislava, Herba 2014; s. 192.
  4. Nakchbandi IA, Merwe SW. Current understanding of osteoporosis associated with liver disease. Nat Rev Gastroenterol Hepatol 2009;6:660-669. Go to original source...
  5. Payer J, Killinger Z a kol. Osteoporóza, Bratislava, Herba 2012; s. 264.
  6. Guichelaar MMJ, Kendall R, Malinchoc M et al. Bone Mineral Density Before and After OLT: Long- term Follow-up and Predictive Factors. Liver Transpl 2006; 12:1390- 1402. Go to original source...
  7. Guanabens N, Parés A, Ros I. Severity of cholestasis and advenced histological stage but not menopuasal status are the major risk factors for osteoporosis in p mary biliary cirrhosis. J Hepatol 2005;42:573- 577. Go to original source...
  8. Carey EJ, Balan V, Kremers WK. Osteopenia and Osteoporosis in Patients With End-Stage Liver Disease Caused by Hepatitis C and Alcoholic Liver Disease: Not just a Cholestatic Problem. Liver Transpl 2003;11:1166-1173. Go to original source...
  9. Hay JE, Guichelaar MM. Evaluation and management of osteoporosis in liver di­ sease. Clin Liver Dis 2005;4:747-766. Go to original source...
  10. Ruiz-Gaspa S, Martinez-Ferrerer A, Guanabens N. Effects of Bilirubin and Sera from Jaundiced Patients on osteoblasts: contribution to th porosis in liver disease. Hepatology 2011;54(6):2104-2113. Go to original source...
  11. Wibaux C, Legroux-Gerot I, Dharancy S et al. Assesing bone status in pati awaiting liver transplantation. Joint Bone Spine 2011;78:387-391. Go to original source...
  12. Monegal A, Navasa M, Guanabens N. Osteoporosis an Bone Mineral metabolism Disorders in Cirrhotic Patie Tisseue Int 1997;60:148-154. Go to original source...




Clinical Osteology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.